Arbor Biotechnologies Announces Acquisition of Serendipity
May 08, 2024 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
Arbor Biotechnologies to Present Data Supporting Therapeutic Programs in PH1 and ALS, and the Discovery of a Novel Type V Nuclease at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
April 22, 2024 17:09 ET
|
Arbor Biotechnologies Inc
- Oral and poster presentations showcase data demonstrating pipeline progress and continued advancement of Arbor’s pipeline programs toward the clinic - Oral presentation with data validating...
4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
January 03, 2024 08:01 ET
|
Arbor Biotechnologies Inc
Partnership brings together two leaders in next-generation genetic medicines to engineer, co-develop and co-commercialize (50:50 profit share) AAV-delivered CRISPR/Cas-based therapeutics for up to six...
Arbor Biotechnologies Appoints Industry Veteran R. Nolan Townsend to Board of Directors
November 07, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer
August 29, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
Arbor Biotechnologies Appoints Deanna M. Petersen as Chief Business Officer
August 07, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
Arbor Biotechnologies to Present at the Stifel 2023 Tailoring Genes: Genetic Medicines Day
May 23, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced Devyn Smith,...
Arbor Biotechnologies Announces Presentations at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy
May 02, 2023 16:30 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that three...
Arbor Biotechnologies Appoints Dr. Daniel Ory as Chief Medical Officer
April 12, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic editing medicines, today announced the...
Arbor Biotechnologies to Present at 2023 Cell & Gene Meeting on the Med
April 06, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that Devyn...